MA26627A1 - Derives de pyrazole et leurs procedes de preparation - Google Patents
Derives de pyrazole et leurs procedes de preparationInfo
- Publication number
- MA26627A1 MA26627A1 MA25567A MA25567A MA26627A1 MA 26627 A1 MA26627 A1 MA 26627A1 MA 25567 A MA25567 A MA 25567A MA 25567 A MA25567 A MA 25567A MA 26627 A1 MA26627 A1 MA 26627A1
- Authority
- MA
- Morocco
- Prior art keywords
- pyrazole derivatives
- processes
- preparation
- methods
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
- C07D231/52—Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8425098P | 1998-05-05 | 1998-05-05 | |
US12241099P | 1999-03-02 | 1999-03-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA26627A1 true MA26627A1 (fr) | 2004-12-20 |
Family
ID=26770756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA25567A MA26627A1 (fr) | 1998-05-05 | 1999-05-03 | Derives de pyrazole et leurs procedes de preparation |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1075467B1 (fr) |
JP (1) | JP3590586B2 (fr) |
KR (1) | KR100404256B1 (fr) |
CN (1) | CN1147476C (fr) |
AT (1) | ATE292118T1 (fr) |
AU (1) | AU765030B2 (fr) |
BR (1) | BR9911013A (fr) |
CA (1) | CA2329065A1 (fr) |
DE (1) | DE69924480D1 (fr) |
HK (1) | HK1037374A1 (fr) |
HR (1) | HRP20000724A2 (fr) |
HU (1) | HUP0101581A3 (fr) |
ID (1) | ID27535A (fr) |
IL (1) | IL139169A0 (fr) |
MA (1) | MA26627A1 (fr) |
NO (1) | NO317985B1 (fr) |
NZ (1) | NZ507558A (fr) |
PL (1) | PL344004A1 (fr) |
RU (1) | RU2000130199A (fr) |
TR (1) | TR200003256T2 (fr) |
TW (1) | TW593282B (fr) |
WO (1) | WO1999057101A1 (fr) |
YU (1) | YU67600A (fr) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2294057A1 (fr) | 1997-06-13 | 1998-12-17 | Smithkline Beecham Corporation | Nouveaux composes de pyrazole et de pyrazoline substitues |
US7301021B2 (en) | 1997-07-02 | 2007-11-27 | Smithkline Beecham Corporation | Substituted imidazole compounds |
US6316466B1 (en) * | 1998-05-05 | 2001-11-13 | Syntex (U.S.A.) Llc | Pyrazole derivatives P-38 MAP kinase inhibitors |
EP1143957A3 (fr) * | 1998-12-16 | 2002-02-27 | Warner-Lambert Company | Traitement de l'arthrite a l'aide d'inhibiteurs de la mek |
AU779089B2 (en) | 1999-04-15 | 2005-01-06 | Bristol-Myers Squibb Holdings Ireland Unlimited Company | Cyclic protein tyrosine kinase inhibitors |
US7125875B2 (en) | 1999-04-15 | 2006-10-24 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
US6472528B1 (en) | 1999-08-10 | 2002-10-29 | Neurocrine Biosciences, Inc. | Synthesis of substituted pyrazolopyrimidines |
US6399621B1 (en) | 1999-08-10 | 2002-06-04 | American Cyanamid Company | N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
US6485746B1 (en) | 2000-08-25 | 2002-11-26 | Neurocrine Biosciences, Inc. | Controlled-release sedative-hypnotic compositions and methods related thereto |
US6384221B1 (en) | 1999-09-02 | 2002-05-07 | Neurocrine Biosciences, Inc. | Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
EP1235814B1 (fr) | 1999-11-23 | 2004-11-03 | Smithkline Beecham Corporation | COMPOSES DE 3,4-DIHYDRO-(1H)QUINAZOLINE-2-ONE UTILISES COMME INHIBITEURS DE LA KINASE CSBP/p38 |
US6864219B2 (en) * | 2000-01-17 | 2005-03-08 | Bayer Aktiengesellschaft | Substituted aryl ketones |
WO2001064669A1 (fr) | 2000-03-03 | 2001-09-07 | Pfizer Products Inc. | Derives d'ether de pyrazole utilises comme agents anti-inflammatoires/analgesiques |
BR0111158A (pt) | 2000-05-12 | 2004-04-06 | Genzyme Corp | Composto e sais fisiológicos do mesmo, método para tratar uma condição mediana por tnf-a em um paciente |
WO2002014305A2 (fr) | 2000-08-17 | 2002-02-21 | Lumera Corporation | Conception et synthese de materiaux optiques non lineaires de pointe destines a des applications electro-optiques |
CZ20022642A3 (cs) * | 2001-08-27 | 2003-09-17 | Pfizer Products Inc. | Způsob výroby dialkylpyridylboranů |
JP2005506324A (ja) | 2001-08-30 | 2005-03-03 | エフ.ホフマン−ラ ロシュ アーゲー | 抗炎症剤としてのアミノピロール化合物 |
ATE349210T1 (de) | 2002-07-09 | 2007-01-15 | Boehringer Ingelheim Pharma | Pharazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege |
AU2003262911A1 (en) | 2002-08-29 | 2004-03-19 | Scios Inc. | Methods of promoting osteogenesis |
JPWO2004029043A1 (ja) | 2002-09-25 | 2006-01-26 | 宇部興産株式会社 | ピラゾール化合物 |
JP4838121B2 (ja) | 2003-06-26 | 2011-12-14 | ノバルティス アーゲー | 5員ヘテロ環を基礎とするp38キナーゼ阻害剤 |
US7244441B2 (en) | 2003-09-25 | 2007-07-17 | Scios, Inc. | Stents and intra-luminal prostheses containing map kinase inhibitors |
MXPA06013912A (es) * | 2004-05-29 | 2007-07-18 | 7Tm Pharma As | Ligandos del receptor de crth2 para usos medicinales. |
US20060035893A1 (en) | 2004-08-07 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
GB0513297D0 (en) * | 2005-06-29 | 2005-08-03 | Glaxo Group Ltd | Novel compounds |
GB0603684D0 (en) * | 2006-02-23 | 2006-04-05 | Novartis Ag | Organic compounds |
WO2008000777A2 (fr) * | 2006-06-29 | 2008-01-03 | Glaxo Group Limited | Nouveaux composés |
GB0621978D0 (en) * | 2006-11-03 | 2006-12-13 | Chroma Therapeutics Ltd | Inhibitors of p38 mitogen-activated protein kinase |
EP1992344A1 (fr) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 alpha comme cible therapeutique pour les maladies associées á une mutation de FGFR3 |
JP5225470B2 (ja) | 2009-08-07 | 2013-07-03 | 中外製薬株式会社 | アミノピラゾール誘導体 |
JP2011201794A (ja) * | 2010-03-24 | 2011-10-13 | Fujifilm Corp | 5−アミノピラゾール誘導体及びその塩の製造方法 |
JP5620417B2 (ja) * | 2011-02-07 | 2014-11-05 | 中外製薬株式会社 | アミノピラゾール誘導体を含む医薬 |
CA2941824C (fr) * | 2013-09-03 | 2020-08-25 | Sareum Limited | Amides d'acide phenylamino-oxazole-4-carboxylique substitues en tant qu'inhibiteurs de la kinase tyk2 |
WO2015099127A1 (fr) | 2013-12-27 | 2015-07-02 | 中外製薬株式会社 | Gène mutant de fgfr gardien et médicament ciblant celui-ci |
WO2016204261A1 (fr) | 2015-06-17 | 2016-12-22 | 中外製薬株式会社 | Dérivés d'aminopyrazole |
GB201612238D0 (en) | 2016-07-14 | 2016-08-31 | Mereo Biopharma 1 Ltd | Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-Yl]-n-cyclopropyl-4-methylbenzamide |
GB201612240D0 (en) | 2016-07-14 | 2016-08-31 | Mereo Biopharma 1 Ltd | Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide |
WO2018059533A1 (fr) * | 2016-09-29 | 2018-04-05 | 南京明德新药研发股份有限公司 | Inhibiteur de la p38α mapk kinase, son procédé de préparation et son utilisation |
LT3691620T (lt) | 2017-10-05 | 2022-09-26 | Fulcrum Therapeutics, Inc. | P38 kinazės inhibitoriai, sumažinantys dux4 ir pasrovinių genų raišką, skirti fshd gydymui |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
EP3563848A1 (fr) * | 2018-04-30 | 2019-11-06 | S.I.S.S.A. Scuola Internazionale Superiore di Studi Avanzati | Inhibiteurs de la serpine pour le traitement des maladies à prions et de type prion |
GB201815695D0 (en) * | 2018-09-26 | 2018-11-07 | Mereo Biopharma 1 Ltd | Synthetic method |
GB201815699D0 (en) * | 2018-09-26 | 2018-11-07 | Mereo Biopharma 1 Ltd | Synthetic method |
US20230025630A1 (en) * | 2018-11-13 | 2023-01-26 | Novartis Ag | Compounds and compositions for treating conditions associated with nlrp activity |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994013643A1 (fr) * | 1992-12-17 | 1994-06-23 | Pfizer Inc. | Pyrazoles et pyrazolopyrimidines presentant une activite d'antagonistes du facteur de liberation de la cortitrophine |
-
1999
- 1999-04-28 CA CA002329065A patent/CA2329065A1/fr not_active Abandoned
- 1999-04-28 ID IDW20002241A patent/ID27535A/id unknown
- 1999-04-28 AU AU40348/99A patent/AU765030B2/en not_active Ceased
- 1999-04-28 DE DE69924480T patent/DE69924480D1/de not_active Expired - Fee Related
- 1999-04-28 KR KR10-2000-7012375A patent/KR100404256B1/ko not_active IP Right Cessation
- 1999-04-28 RU RU2000130199/04A patent/RU2000130199A/ru not_active Application Discontinuation
- 1999-04-28 TR TR2000/03256T patent/TR200003256T2/xx unknown
- 1999-04-28 AT AT99923484T patent/ATE292118T1/de not_active IP Right Cessation
- 1999-04-28 YU YU67600A patent/YU67600A/sh unknown
- 1999-04-28 BR BR9911013-0A patent/BR9911013A/pt not_active IP Right Cessation
- 1999-04-28 PL PL99344004A patent/PL344004A1/xx not_active Application Discontinuation
- 1999-04-28 IL IL13916999A patent/IL139169A0/xx unknown
- 1999-04-28 HU HU0101581A patent/HUP0101581A3/hu unknown
- 1999-04-28 NZ NZ507558A patent/NZ507558A/en unknown
- 1999-04-28 EP EP99923484A patent/EP1075467B1/fr not_active Expired - Lifetime
- 1999-04-28 JP JP2000547071A patent/JP3590586B2/ja not_active Expired - Fee Related
- 1999-04-28 WO PCT/EP1999/002879 patent/WO1999057101A1/fr not_active Application Discontinuation
- 1999-04-28 CN CNB998060046A patent/CN1147476C/zh not_active Expired - Fee Related
- 1999-05-03 MA MA25567A patent/MA26627A1/fr unknown
- 1999-05-05 TW TW088107268A patent/TW593282B/zh not_active IP Right Cessation
-
2000
- 2000-10-25 HR HR20000724A patent/HRP20000724A2/hr not_active Application Discontinuation
- 2000-11-02 NO NO20005535A patent/NO317985B1/no not_active IP Right Cessation
-
2001
- 2001-11-22 HK HK01108233A patent/HK1037374A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1075467B1 (fr) | 2005-03-30 |
JP2002513784A (ja) | 2002-05-14 |
WO1999057101A1 (fr) | 1999-11-11 |
NZ507558A (en) | 2003-08-29 |
HUP0101581A2 (hu) | 2002-03-28 |
NO20005535D0 (no) | 2000-11-02 |
HRP20000724A2 (en) | 2001-06-30 |
KR100404256B1 (ko) | 2003-11-01 |
ID27535A (id) | 2001-04-12 |
YU67600A (sh) | 2003-07-07 |
HK1037374A1 (en) | 2002-02-08 |
CA2329065A1 (fr) | 1999-11-11 |
DE69924480D1 (en) | 2005-05-04 |
AU765030B2 (en) | 2003-09-04 |
NO317985B1 (no) | 2005-01-17 |
EP1075467A1 (fr) | 2001-02-14 |
TR200003256T2 (tr) | 2001-04-20 |
NO20005535L (no) | 2000-11-02 |
ATE292118T1 (de) | 2005-04-15 |
AU4034899A (en) | 1999-11-23 |
RU2000130199A (ru) | 2002-11-10 |
PL344004A1 (en) | 2001-09-10 |
KR20010043363A (ko) | 2001-05-25 |
CN1147476C (zh) | 2004-04-28 |
BR9911013A (pt) | 2001-02-06 |
IL139169A0 (en) | 2001-11-25 |
TW593282B (en) | 2004-06-21 |
JP3590586B2 (ja) | 2004-11-17 |
HUP0101581A3 (en) | 2002-07-29 |
CN1300282A (zh) | 2001-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA26627A1 (fr) | Derives de pyrazole et leurs procedes de preparation | |
DE69824029D1 (de) | Bicyclische kinase inhibitoren | |
BR0014225A (pt) | Derivados de pirazol | |
MXPA02011320A (es) | Derivados de pirazol triciclico como inhibidores de cinasa. | |
MXPA03010207A (es) | Nuevas 4-anilinoquinolin-3-carboxamidas. | |
DE60204452D1 (de) | Pyrazolo[1,5]pyridinderivate | |
DE69617273D1 (de) | Heterocyclisch substituierte cyclopentanderivate. | |
ATE316083T1 (de) | Adamantanderivate | |
BG105481A (en) | Tricyclic pyrazole derivatives | |
ATE300541T1 (de) | Pyrazolopyridinderivate | |
UA83648C2 (ru) | Антагонисты аденозиндифосфатного рецептора тромбоцитов | |
DE60004340D1 (de) | Substituierte 1,4-dihydroindeno[1,2-c]pyrazole als inhibitoren von tyrosinkinase | |
ATE274515T1 (de) | Pyrazolopyridinderivate | |
SE9904128D0 (sv) | Novel compounds | |
ECSP992945A (es) | Derivados de pirazol |